Search by Drug Name or NDC
NDC 23731-6030-01 triCitrasol 14 g/30mL Details
triCitrasol 14 g/30mL
triCitrasol is a EXTRACORPOREAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Citra Labs LLC. The primary component is TRISODIUM CITRATE DIHYDRATE.
Product Information
| NDC | 23731-6030 |
|---|---|
| Product ID | 23731-6030_49d76384-a8fa-44ed-99b4-1f75ee4a435d |
| Associated GPIs | 83400080101320 |
| GCN Sequence Number | 042989 |
| GCN Sequence Number Description | sodium citrate dihydrate VIAL 46.7 % INJECTION |
| HIC3 | M9J |
| HIC3 Description | CITRATES AS ANTICOAGULANTS |
| GCN | 25621 |
| HICL Sequence Number | 018559 |
| HICL Sequence Number Description | SODIUM CITRATE DIHYDRATE |
| Brand/Generic | Brand |
| Proprietary Name | triCitrasol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Trisodium Citrate dihydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | EXTRACORPOREAL |
| Active Ingredient Strength | 14 |
| Active Ingredient Units | g/30mL |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Labeler Name | Citra Labs LLC |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | BN010409 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23731-6030-01 (23731603001)
| NDC Package Code | 23731-6030-1 |
|---|---|
| Billing NDC | 23731603001 |
| Package | 10 VIAL, SINGLE-USE in 1 CASE (23731-6030-1) / 30 mL in 1 VIAL, SINGLE-USE (23731-6030-3) |
| Marketing Start Date | 2003-07-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |